SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-012595
Filing Date
2019-08-14
Accepted
2019-08-14 16:44:52
Documents
48
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 436294
2 ex31-1.htm EX-31.1 20053
3 ex31-2.htm EX-31.2 19939
4 ex32-1.htm EX-32.1 10589
  Complete submission text file 0001493152-19-012595.txt   2701253

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE ptix-20190630.xml EX-101.INS 466480
6 XBRL SCHEMA FILE ptix-20190630.xsd EX-101.SCH 36490
7 XBRL CALCULATION FILE ptix-20190630_cal.xml EX-101.CAL 37206
8 XBRL DEFINITION FILE ptix-20190630_def.xml EX-101.DEF 132568
9 XBRL LABEL FILE ptix-20190630_lab.xml EX-101.LAB 256128
10 XBRL PRESENTATION FILE ptix-20190630_pre.xml EX-101.PRE 196684
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

IRS No.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51353 | Film No.: 191027179
SIC: 7389 Services-Business Services, NEC